Karma Rabon-Stith, PhD., MBA, PMPGlobal Oncology Real World Evidence Lead at Pfizer, Inc.Speaker
Profile
Currently the Global Oncology Real World Evidence Lead at Pfizer, Dr Karma Rabon-Stith is a Pharmaceutical Executive with over 15+years of Biopharmaceutical Industry experience. She is a PhD trained scientist and Epidemiologist with solid experience leading cross-functional drug development teams. Dr Rabon-Stith’s background in drug development spans a broad spectrum of therapeutic areas, including oncology, respiratory, autoimmune, cardiovascular, metabolic and atopic dermatitis. She has also worked across various stages of development with experience in pre-clinical, early and late development, and post-marketing development. Over the last fifteen years, Dr Rabon-Stith has lead cross functional work and have established solid relationships with high profile external stakeholders. She has been responsible for developing ground-breaking and innovative digital resources which have been recognized as "best-in-class" within the organization and have been adopted across all therapy areas.
Agenda Sessions
A Practical Best Practices Approach to Ensuring Real World Data Quality and Reliable Real World Evidence is Fit-for-purpose
, 12:10pmView Session